WallStSmart
STIM

Neuronetics Inc

NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES

$1.94
+14.12% today

Updated 2026-04-30

Market cap
$117.59M
P/E ratio
P/S ratio
0.79x
EPS (TTM)
$-0.59
Dividend yield
52W range
$1 – $5
Volume
1.9M

Neuronetics Inc (STIM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-43.2%
Last 4 quarters
Revenue YoY growth
+85.7%
Most recent quarter
EPS YoY growth
+69.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-1.1%
2025-11-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-17$-0.10-8.5%$1.36$1.35-0.7%
2025-11-04$-0.13+0.0%$2.77$2.74-1.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.09$-0.10-8.5%$41.78M+85.7%
2025-09-30$-0.13$-0.13+0.0%$37.30M+101.3%
2025-06-30$-0.08$-0.15-87.5%$38.11M+131.7%
2025-03-31$-0.12$-0.21-76.7%$31.98M+83.6%
2024-12-31$-0.24$-0.33-37.5%$22.49M+10.7%
2024-09-30$-0.23$-0.44-91.7%$18.53M+3.6%
2024-06-30$-0.27$-0.33-22.2%$16.45M-6.6%
2024-03-31$-0.31$-0.27+12.9%$17.42M+12.1%
2023-12-31$-0.26$-0.19+26.9%$20.31M
2023-09-30$-0.31$-0.33-6.5%$17.88M
2023-06-30$-0.35$-0.17+51.4%$17.61M
2023-03-31$-0.39$-0.38+2.6%$15.54M

Frequently asked questions

Has Neuronetics Inc beaten earnings estimates?
Neuronetics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -43.2% over the last 4 quarters.
How does STIM stock react to earnings?
STIM stock has moved an average of -0.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Neuronetics Inc's revenue growth rate?
Neuronetics Inc reported year-over-year revenue growth of +85.7% in its most recent quarter, with EPS growing +69.7% year-over-year.